Riskpilot← Back to searchSign inGet full accessILEXIS AB
ABActiveOrg 5566433156Blåklintsgatan 4Other software publishing · NACE 5829Est. 20034 employees
Revenue 2025
SEK 4,6M
-8% vs 2024
EBITDA margin
10.0%
+45% vs 2024
Equity ratio
54.0%
Financial strength
Net profit 2025
SEK 348K
+48% vs 2024
| Revenue | SEK 4,6M | -8% |
| EBITDA | SEK 458K | +45% |
| Net profit | SEK 348K | +48% |
| Total assets | SEK 1M | -31% |
| Equity | SEK 557K | +24% |
| Employees | 4 | — |
Legal name
ILEXIS AB
Org number
5566433156
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
16 april 2003
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva utveckling och försäljning av dentala dataprogramvaror och utrustning samt därmed förenlig verksamhet.
Address
Blåklintsgatan 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 077 | 3 703 | 4 945 | 5 009 | 4 588 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 407 | 136 | 313 | 315 | 458 |
| Depreciation & amort. | −21 | −21 | −0 | −0 | −0 |
| EBIT | 386 | 115 | 313 | 315 | 458 |
| Net financials | — | −2 | −5 | −2 | −8 |
| Profit before tax | 385 | 113 | 308 | 313 | 450 |
| Tax | −90 | −34 | −76 | −78 | −102 |
| Net profit | 295 | 79 | 232 | 235 | 348 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 163 | 1 142 | 1 563 | 1 504 | 1 031 |
| Equity | 518 | 237 | 394 | 449 | 557 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 645 | 905 | 1 169 | 1 055 | 474 |
| Total debt | 1 645 | 905 | 1 169 | 1 055 | 474 |
EBITDA margin
10.0%
This company
15.8%
Market median
-37% vs market
20212025
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
62.5%
This company
18.4%
Market median
+240% vs market
20212025
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
20212025
Asset turnover
4.45×
This company
1.12×
Market median
+297% vs market
20212025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ILEXIS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tobias Olof Kenneth Pettersson | Audit | 0 companies |
| Per Tomas Lock | Board of Directors | 0 companies |
| Bengt Daniel Schmeling | Board of Directors | 0 companies |
| Anders Hjalmar Blom | Chairman | 0 companies |